Riess JW, Reckamp KL, Frankel P, Longmate J, et al. Erlotinib and Onalespib Lactate Focused on EGFR Exon 20 Insertion Non-Small Cell Lung Cancer (NSCLC): A California Cancer Consortium Phase I/II Trial (NCI 9878). Clin Lung Cancer 2021 May 15. pii: S1525-7304(21)00094.
PMID: 34140248